Kari Furu
Research Professor
Responsibilities
Kari Furu's main research interest is in perinatal pharmacoepidemiology. She has long experience with combining data from many Norwegian and Nordic national registers. Furu's current research focus is on prescription drug exposures among pregnant women and short and long-term outcomes in the child. Furu leads and collaborates in several international research groups on drug safety in pregnancy.
Projects and publications
- ADHD medication in pregnancy: understanding the population and outcomes related to treatment use and discontinuation
- Developmental profiles and co-occurring difficulties in children with autism spectrum conditions in Norway
- Epidemiological studies on benefits and harms of drug treatment – special focus on drug safety in pregnancy and childhood.
- GOMAP: global observasjonsstudie av bruk av psykofarmakologiske legemidler
- Prescription drug use and subsequent morbidity and mortality
- Psykofarmaka inkludert bruk av ADHD medisiner under graviditet - innsikt fra MoBa undersøkelsen
- Sikker COVID-19 vaksinering under svangerskapet
- Sikkerhetsstudie av brodalumab – en multinasjonal registerstudie (BRAHMS)